View Linkedin View Twitter

About Aviceda

Aviceda Therapeutics is a late clinical-stage biotechnology company focused on harnessing the promise of immune cells’ natural checkpoints, which modulate innate and adaptive immune activity that is dysregulated in a diverse range of diseases characterized by chronic non-resolving inflammation.

Ali Khanehzar team member photo

Ali Khanehzar, PhD

Diyan Patel team member photo

Diyan Patel, MS

Senior Research Associate & Lab Manager
Ravinder Earla team member photo

Ravinder Earla, PhD

Associate Director-Bioanalytical ADME
Kinkini Roy team member photo

Kinkini Roy, PhD

Associate Director, Formulation Development
Sheri Peterson team member photo

Sheri Peterson, PhD

Senior Scientist-Neurology
Sunny Christian team member photo

Sunny Christian

Senior Manager- CMC
Victor Sendra team member photo

Victor Sendra, PhD

Senior Scientist-Glycoimmunology
Keri Marchitto team member photo

Keri Marchitto

Director-Clinical Operations
Vincenzo Maddalena team member photo

Vincenzo Maddalena

Associate Director, Clinical Program Management
Dawn McNeal team member photo

Dawn McNeal

Clinical Trial Manager
Laura Holm team member photo

Laura Holm

Clinical Research Associate
Vanessa Cordeiro team member photo

Vanessa Cordeiro

Senior Manager, Accounting
Ryan Goodwin team member photo

Ryan Goodwin

HR and Talent Acquisition Lead
Adele Fleury team member photo

Adele Fleury

Sr. Exec Admin & Corporate Dev
Monika Witczak team member photo

Monika Witczak

Executive Assistant & Office Manager

Christopher Scott, PhD

Scientific Co-Founder

Mohamed Genead, MD

Co-Founder, CEO & President

Derek Kunimoto, MD, JD

Co-Founder & Chief Strategy Officer, Head of Clinical Development

Michael Tolentino, MD

Co-Founder & Chief Innovation Officer

Our partners

Logo Complex Carbohydrate Research Center University of Georgia Logo Queen's University Belfast Logo Aviceda Glycotech, Ltd